Evidence map›Paper›PMID 42197421›Full record

ArticleMicroorganisms2026

Probiotic-Induced Gut Microbiota Modulation: A Comparative Analysis Using 16S rRNA V3-V4 and Targeted Sequencing.

Han Lee, Gaeun Kim, Jungeun Kim, OneZoong Kim, Sung-Hee Jung, Sunghee Hyun, Chang Seok Oh

Abstract read
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Han LeeDepartment of Biomedical Laboratory Science, Graduate School, Eulji University, Uijeongbu 11759, Republic of Korea.ORCID 0000-0002-9367-8501
Gaeun KimDepartment of Biomedical Laboratory Science, Graduate School, Eulji University, Uijeongbu 11759, Republic of Korea.ORCID 0009-0004-0168-283X
Jungeun KimDepartment of Biomedical Laboratory Science, Graduate School, Eulji University, Uijeongbu 11759, Republic of Korea.ORCID 0009-0003-1774-3855
OneZoong KimDepartment of Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul 07345, Republic of Korea.ORCID 0000-0001-5544-6825
Sung-Hee JungDepartment of Gastroenterology, Daejeon Eulji University Hospital, Eulji University, Daejeon 35233, Republic of Korea.
Sunghee HyunDepartment of Biomedical Laboratory Science, Graduate School, Eulji University, Uijeongbu 11759, Republic of Korea.ORCID 0000-0002-8980-1036
Chang Seok OhDepartment of Mortuary Science, College of Bio-Convergence, Eulji University, Seongnam 13135, Republic of Korea.

Funding

eulji university EJRG-24-10
6 · The paper itself

Abstract

Standard 16S rRNA V3-V4 sequencing encounters primer mismatch issues and insufficient taxonomic resolution, hindering the accurate quantification of specific, low-abundance taxa, such as administered probiotic strains. Therefore, we empirically compared outcomes between the standard V3-V4 method and high-resolution targeted species sequencing (TSS) to assess bias and establish reliability metrics for probiotic efficacy assessments. A longitudinal pilot study was conducted over nine weeks in older participants receiving synbiotic supplementation; their fecal samples were collected and analyzed. V3-V4 analysis successfully captured a significant transient reduction in alpha-diversity with multidirectional genus-level fluctuations. However, taxonomic overlap between these two methods was high at the phylum level and sharply declined to 6.7% at the species level. Notably, compared with V3-V4 sequencing, TSS could successfully quantify the abundance of administered

Indexed as

16S rRNAgut microbiotaprobioticstarget species

Identifiers

PMID42197421
PMCPMC13210024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.